Onconetix, Inc. (ONCO) stock
ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$3.15+0.15 (+5.00%)
Close on Nov 18, 2026Market cap $12.44MP/E –Yield –
Onconetix operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Onconetix's operating cash flow for the twelve months ending Jun 30, 2026 was -$10.31M. For fiscal 2025 it was -$9.68M. The highest annual figure on record is -$2.04M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.68M | – |
| FY2024 | Dec 31, 2024 | -$10.50M | – |
| FY2023 | Dec 31, 2023 | -$13.58M | – |
| FY2022 | Dec 31, 2022 | -$8.68M | – |
| FY2021 | Dec 31, 2021 | -$2.04M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.92M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.12M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.09M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.18M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.41M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.00M | – |
| Q4 FY2024 | Dec 31, 2024 | -$917.65K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.15M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.20M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.23M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.31M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.04M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.80M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.81M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.17M | – |
| Q1 FY2022 | Mar 31, 2022 | -$886.09K | – |
| Q4 FY2021 | Dec 31, 2021 | -$674.40K | – |
| Q3 FY2021 | Sep 30, 2021 | -$730.48K | – |
| Q2 FY2021 | Jun 30, 2021 | -$382.81K | – |
| Q1 FY2021 | Mar 31, 2021 | -$256.55K | – |
See a number that looks wrong?